New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 18, 2017 – Symbiomix Therapeutics announced the FDA approval of Solosec (secnidazole), for the treatment of bacterial vaginosis (BV) in adult women.
Download PDF
Return to publications
